United States · FDA National Drug Code directory
fexofenadine hcl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-202_2a0b48b8-5955-9ab7-e063-6394a90a6b24
- Product NDC
- 50228-202
- Form
- TABLET, FILM COATED
- Composition / generic term
- fexofenadine hcl
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141226
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (50228-202-01) · 50228-202-01
- 1000 TABLET, FILM COATED in 1 BOTTLE (50228-202-02) · 50228-202-02
- 30 TABLET, FILM COATED in 1 BOTTLE (50228-202-03) · 50228-202-03
- 1000 TABLET, FILM COATED in 1 BOTTLE (50228-202-04) · 50228-202-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →